A 2008 Cochrane Collaboration meta-analysis of previous studies concluded that evidence exists of "a significant benefit in symptom control and physiologic outcomes" for an extract of hawthorn used as an adjuvant in treating chronic heart failure.[24] A 2010 review[25] concluded that "Crataegus [hawthorn] preparations hold significant potential as a useful remedy in the treatment of cardiovascular disease".